GU Cancers 2020 | Genetic risk assessment for hereditary RCC
VJOncology is committed to improving our service to you
Thanks for your feedback, this will help us improve our content for you!
Michael Daneshvar, MD, SUNY Upstate Medical Center, Syracuse, NY, discusses a report from the consensus panel on the genetic risk assessment for hereditary renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.
Get great new content delivered to your inboxSign up